ZHENGZHOU , January 14 , SinoCast -- Henan Taloph Pharmaceutical Stock Co., Ltd. (SHSE: 600222) predicted net profit attributable to shareholders to rise 70% to 80% from a year earlier in 2013. The figure was CNY 20.1986 million a year ago.
Most Popular Stories
- Ukraine Crisis Limits Losses in Gold, Silver
- Can GOP Dodge Immigration Bullet?
- Software Writers Sought in Indiana
- Chiquita, Fyffes to Form Top Banana
- Photo ID Required for Unemployment Benefits
- Big Earthquake Rumbles Northern California
- China's Money Rate Drops on Slowdown Concern
- Mt. Gox Files for Bankruptcy in U.S.
- Tech Firms to Increase Hiring for 4th Year in a Row
- '300' Sequel Conquers Box Office Foes